Brief: Theravance Biopharma, Inc. Announces Appointment Of Jim Kelly, Managing Director At Weiss Asset Management, To Board Of Directors
April 11 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA, INC. ANNOUNCES APPOINTMENT OF JIM
KELLY,
MANAGING DIRECTOR AT WEISS ASSET MANAGEMENT, TO BOARD OF
DIRECTORS
* THERAVANCE BIOPHARMA INC - WITH APPOINTMENT OF KELLY, FOUR
NEW
DIRECTORS HAVE JOINED COMPANY'S BOARD OF DIRECTORS SINCE 2018
Source text for Eikon: ID:nPn4bjY64a
Further company coverage: TBPH.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions